I'm often struck by how the media spins the supposed wonders of GLP-1 agonists, claiming they reduce risks for everything from heart attacks to uterine fibroids. It gets under my skin when these claims are pushed without mentioning who's really behind the research, like Noble Nordisk or Eli Lilly. Why is it that these critical details are so often left out of the conversation?

Martha Rosenbergis a health reporter and the author ofBig Food, Big Pharma, Big LiesandBorn With a Junk Food Deficiency.

SUBSCRIBE TO THE PODCAST https://www.kevinmd.com/podcast